Coenzyme Q10 is one of 196 small molecule programs targeting Aphthous Ulcer. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
71 competitors in Polycystic Ovary Syndrome
Glucophage
Femara
Ozempic
Avandia
Daliresp
Myrbetriq
Onglyza
Calciferol
Glucophage
Tradjenta
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details